Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

Investors

Analysts

Theratechnologies is followed by the analysts indicated below. The opinions, estimates or forecasts made by these analysts do not reflect the opinions, estimates or forecasts of Theratechnologies or its management. By referring to the analyst indicated below, Theratechnologies in no way endorses these opinions, estimates and forecasts.

Bloom Burton & Co, Philippa Flint 416 640-7584

BMO Capital Markets, Jason Zhang 212 885-4179

Canaccord Adams, Neil Maruoka 416 869-3073

Desjardins Securities, Maher Yaghi 514 281-8664

Dundee Securities, David Martin 416 350-3477

GMP Securities, Cosme Ordonez 514 288-9279

Loewen, Ondaatje, McCutcheon Limited, Richard T. Timmer 416 964-4430

RBC Capital Markets, Douglas Miehm 416 842-7823

Versant Partners, Douglas W. Loe 416 849-5005